PaulMRidkerMD

PubMed

• 5480 citations
  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
  Paul M. Ridker, Brendan M. Everett, Tom Thuren, Jean G. MacFadyen, William Chang
  The New England Journal of Medicine. 2017-08-27
• 344 citations
  Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: Analyses from the Canakinumab Anti-Inflammato...
  Paul M. Ridker, Peter Libby, Jean G. MacFadyen, Tom Thuren, Christie M. Ballantyne
  European Heart Journal. 2018-10-07
• 193 citations
  Sex Hormone Levels and Risk of Cardiovascular Events in Postmenopausal Women
  Kathryn M. Rexrode, JoAnn E. Manson, I-Min Lee, Paul M. Ridker, Patrick M. Sluss
  Circulation. 2003-10-07

Journal Articles

• Association of Lipid, Inflammatory, and Metabolic Biomarkers with Age at Onset for Incident Coronary Heart Disease in Women  
  Sagar B Dugani, Alawi A Alsheikh-Ali, Paul M Ridker, Samia Mora, JAMA Cardiology
• Targeting Interleukin-1 and Interleukin-6  
  Paul Ridker, MD, JACC: Cardiovascular Imaging
• Inflammation, Immunity, and Infection in Atherothrombosis  
  Paul M Ridker, Valentin Fuster, Priscilla Y Hsue, Peter Libby, ScienceDirect
• Meta-Analysis of LDL-C Lowering and Mortality  
  Paul M Ridker, Edward K Duran, JAMA
• Relationship of Interleukin-1β Blockade with Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial  
  Daniel H Solomon, Paul M Ridker, Brendan M Everett, Peter Libby, Annals of Internal Medicine
• Modulation of the Interleukin-6 Signalling Pathway and Incidence Rates of Atherosclerotic Events and All-Cause Mortality: Analyses from the Canakinumab Anti-Inflammato...  
  Paul M Ridker, Brendan M Everett, Christie Ballantyne, Peter Libby, European Heart Journal
• Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort from the Women’s Health Initiative  
  Marian C Limacher, Lisa W Martin, Paul M Ridker, Nancy R Cook, Jennifer G Robinson, Monika M Safford, Nanette K Wenger, Samia Mora, JoAnn E Manson, JAMA
• Original Investigation Lipoprotein(A) and Cardiovascular Risk Prediction Among Women  
  Samia Mora, Paul M Ridker, Nancy R Cook, ScienceDirect
• Genome-Wide Meta-Analysis of Macronutrient Intake of 91,114 European Ancestry Participants from the Cohorts for Heart and Aging Research in Genomic Epidemiology Consor...  
  Paul M Ridker, Nature
• Lipoprotein(A) and Cardiovascular Risk Prediction Among Women  
  Samia Mora, Paul M Ridker, JACC: Cardiovascular Imaging
• Effect of Interleukin-1β Inhibition with Canakinumab on Incident Lung Cancer in Patients with Atherosclerosis: Exploratory Results from a Randomised, Double-Blind, Pla...  
  Paul Ridker, MD, The Lancet
• Join now to see all

Lectures

• Association of Migraine with Aura and Other Risk Factors with Incident Cardiovascular Disease in Women 
  Harvard Medical School, Boston, Massachusetts - 10/18/2012
• Braunwald Keynote: 100 Years from CRP to Anti-Cytokine Therapy for Atherosclerosis 
  2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
• Inflammation as a Target of Therapy. 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
• Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk 
  American College of Cardiology, 58th Annual Scientific Session & Expo, Orlando, Florida, USA
• Should Aspirin Be Used for Primary Prevention in the Post-Statin Era? 
  58th Annual Scientific Session & Expo, Orlando, Florida, USA
• Join now to see all